Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Guerci

Showing results (51-60 of 113) with videos related to

Pageof 12
Sort By:
Surgery|November 19, 2023
Patients with prediabetes improve insulin resistance after surgery for primary hyperparathyroidismClaire Nomine-Criqui, Florence Bihain, Phi-Linh Nguyen-Thi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 9, 2013
Peroxisome proliferator-activated receptor-γ mutations responsible for lipodystrophy with severe hypertension activate the cellular renin-angiotensin systemMartine Auclair, Corinne Vigouroux, Franck Boccara, et al.
Diabetes & Metabolism|February 13, 2023
Dulaglutide and insulin microsecretion in people with type 1 diabetes (DIAMOND-GLP-1): A randomized double-blind placebo-controlled trialCharles Thivolet, Etienne Larger, Bertrand Cariou, et al.
Diabetes Technology & Therapeutics|May 23, 2022
Reduced Rate of Acute Diabetes Events with Flash Glucose Monitoring Is Sustained for 2 Years After Initiation: Extended Outcomes from the RELIEF StudyJean-Pierre Riveline, Ronan Roussel, Eric Vicaut, et al.
Cardiovascular Diabetology|September 5, 2015
Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide studyRafael Simó, Bruno Guerci, Guntram Schernthaner, et al.
Atherosclerosis|October 20, 2009
Impact of android overweight or obesity and insulin resistance on basal and postprandial SR-BI and ABCA1-mediated serum cholesterol efflux capacitiesNesrine Attia, Natalie Fournier, Benoît Vedie, et al.
Diabetes Technology & Therapeutics|August 13, 2013
ProAct study: new features of insulin pumps improve diabetes management and glycemic control in patients after transition of continuous subcutaneous insulin infusion systemsRalph Ziegler, Claudio Tubili, Ana Chico, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 21, 2012
Patients with Type 2 Diabetes Initiating Exenatide Twice Daily or Insulin in Clinical Practice: CHOICE StudyStephan Matthaei, Matthew Reaney, Chantal Mathieu, et al.
Health and Quality of Life Outcomes|December 28, 2013
Patient-reported outcomes among patients using exenatide twice daily or insulin in clinical practice in six European countries: the CHOICE prospective observational studyMatthew Reaney, Chantal Mathieu, Claes-Göran Ostenson, et al.
Clinics and Research in Hepatology and Gastroenterology|December 18, 2021
Awareness of chronic liver diseases, a comparison between diabetologists and general practitionersClémence M Canivet, Sarra Smati, Adrien Lannes, et al.
Pageof 12

Showing results (51-60 of 113) with videos related to

Sort By:
Pageof 12
Surgery|November 19, 2023
Patients with prediabetes improve insulin resistance after surgery for primary hyperparathyroidismClaire Nomine-Criqui, Florence Bihain, Phi-Linh Nguyen-Thi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 9, 2013
Peroxisome proliferator-activated receptor-γ mutations responsible for lipodystrophy with severe hypertension activate the cellular renin-angiotensin systemMartine Auclair, Corinne Vigouroux, Franck Boccara, et al.
Diabetes & Metabolism|February 13, 2023
Dulaglutide and insulin microsecretion in people with type 1 diabetes (DIAMOND-GLP-1): A randomized double-blind placebo-controlled trialCharles Thivolet, Etienne Larger, Bertrand Cariou, et al.
Diabetes Technology & Therapeutics|May 23, 2022
Reduced Rate of Acute Diabetes Events with Flash Glucose Monitoring Is Sustained for 2 Years After Initiation: Extended Outcomes from the RELIEF StudyJean-Pierre Riveline, Ronan Roussel, Eric Vicaut, et al.
Cardiovascular Diabetology|September 5, 2015
Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide studyRafael Simó, Bruno Guerci, Guntram Schernthaner, et al.
Atherosclerosis|October 20, 2009
Impact of android overweight or obesity and insulin resistance on basal and postprandial SR-BI and ABCA1-mediated serum cholesterol efflux capacitiesNesrine Attia, Natalie Fournier, Benoît Vedie, et al.
Diabetes Technology & Therapeutics|August 13, 2013
ProAct study: new features of insulin pumps improve diabetes management and glycemic control in patients after transition of continuous subcutaneous insulin infusion systemsRalph Ziegler, Claudio Tubili, Ana Chico, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 21, 2012
Patients with Type 2 Diabetes Initiating Exenatide Twice Daily or Insulin in Clinical Practice: CHOICE StudyStephan Matthaei, Matthew Reaney, Chantal Mathieu, et al.
Health and Quality of Life Outcomes|December 28, 2013
Patient-reported outcomes among patients using exenatide twice daily or insulin in clinical practice in six European countries: the CHOICE prospective observational studyMatthew Reaney, Chantal Mathieu, Claes-Göran Ostenson, et al.
Clinics and Research in Hepatology and Gastroenterology|December 18, 2021
Awareness of chronic liver diseases, a comparison between diabetologists and general practitionersClémence M Canivet, Sarra Smati, Adrien Lannes, et al.
Pageof 12